Publications

  1. Davis, E.M., Pottala, J.V., Bohlmeyer, T., Murphy, K., Rieck, L.D. and Egland, K.A. Association of CAPC with HER-2 Negative Ductal Carcinoma in situ of the Breast as an Early Stage Biomarker for American Indian Women. Submitted Arch Pathol Lab Med.
  2. Watson, A.P. and Egland, K.A. Pathways to Personalized Medicine for Breast and Prostate Cancers: Emerging Diagnostic Methods and Prognostic Biomarkers. South Dakota Medicine. Accepted, In Press June 2010.
  3. Johnson, B.P., Jensen, B.J., Ransom, E.M., Heinemann, K.A., Vannatta, K.M., Egland, K.A. and Egland, P.G. Interspecies Signaling Between Veillonella atypica and Streptococcus gordonii Requires the Transcription Factor CcpA. J. Bacteriol. 191:5563-5565, 2009. PMID: 19542285.
  4. Rieck, L.D., Pottala, J.V., Eliason, S.L., Koch, M.R.D., Egland, P.G., and Egland, K.A. Defining the Status of HER-2 Gene Amplification in Native American Women. Cancer Genet Cytogenet. 187:54-6, 2008. PMID: 18992644.
  5. Ramaeker, D., Brannian, J., Egland, K.A., McCaul, K. and Hansen, K. When is an elevated testosterone not testosterone? When it is an immunoassay interfering antibody. Fertil. Steril. 90:886-888, 2008. PMID: 17953956.
  6. Egland, K.A., Liu, X. F., Squires, S., Nagata, S., Man, Y.-G., Bera, T.K., Vincent, J.J., Strausberg, R., Lee, B.K. and Pastan, I.: High expression of a novel cytokeratin associated protein in many cancers. Proc. Natl. Acad. Sci. USA 103: 5929-5934, 2006. PMID: 16585525.
  7. Korherr, C., Gille, H., Schäfer, R., Koenig-Hoffmann, K., Dixelius, J., Egland, K.A., Pastan, I. and Brinkmann, U.: Identification of novel pro-angiogenic genes and pathways by high throughput functional genomics: TBK1 and the IRF3 pathway. Proc. Natl. Acad. Sci. USA 103: 4240-4245, 2006. PMID: 16537515.
  8. Egland, K.A., Vincent, J.J., Strausberg, R., Lee, B.K. and Pastan, I.: Discovery of the breast cancer gene BASE using a molecular approach to enrich for genes encoding membrane and secreted proteins. Proc. Natl. Acad. Sci. USA 100: 1099-1104, 2003. PMID: 12538848.
  9. Egland, K.A., Kumar, V., Duray, P. and Pastan, I.: Characterization of overlapping XAGE-1 transcripts encoding a cancer testis antigen expressed in lung, breast, and other types of cancers. Mol. Cancer Ther. 1: 441-450, 2002. PMID: 12479262.
  10. Egland, K.A., Kumar, V., Duray, P. and Pastan, I.: Cover photograph. Mol. Cancer Ther. 1, 2002. PMID: 12479262.
  11. Egland, K.A. and Greenberg, E.P.: Quorum sensing in Vibrio fischeri: analysis of the LuxR DNA binding region by alanine-scanning mutagenesis. J. Bacteriol. 183: 382-386, 2001. PMID: 11114939.
  12. Egland, K.A. and Greenberg, E.P.: Conversion of the Vibrio fischeri transcriptional activator, LuxR, to a repressor. J. Bacteriol. 182: 805-811, 2000. PMID: 10633117.
  13. Egland, K.A. and Greenberg, E.P.: Quorum sensing in Vibrio fischeri: elements of the luxI promoter. Mol. Microbiol. 31: 1197-1204, 1999. PMID: 10096086.
  14. Zabner, J., Fasbender, A.J., Moninger, T., Poellinger, K.A. and Welsh, M.J.: Cellular and molecular barriers to gene transfer by a cationic lipid. J. Biol. Chem. 270: 18997-19007, 1995. PMID: 7642560.